- Source type
- Review
- Access type
- Abstract/index
- Publisher
- PubMed
- Indexed by
- PubMed
- Added
- 2026-06-27
Trust profile
91
Government health research
- Publisher type
- Government research
- Bias profile
- Low
Best used for
- Research synthesis
- Public-health context
- Safety resources
Weak for
- Primary endpoint extraction when a study is available
Used in Viral Vitalism
Why Your Wearable Data Can Mislead You
Roles: Supporting evidence
Claims supported
No reusable evidence claims are currently attached to this source.
Related studies
No structured study record is currently attached to this source.
Related sources
About Sleep
U.S. public-health context on sleep duration, quality, disorders, and adult sleep guidance.
- Trust score
- 91
- Publisher
- Centers for Disease Control and Prevention
- Access
- Official
- Usage
- 6 connections
CDC: Steps for Losing Weight
Centers for Disease Control and Prevention used across the Viral Vitalism evidence library.
- Trust score
- 91
- Publisher
- Centers for Disease Control and Prevention
- Access
- Official
- Usage
- 7 connections
FDA: First Over-the-Counter Continuous Glucose Monitor for Children
Canonicalized from rapid brief fda-otc-cgm-children-dexcom-stelo.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 1 connection
Daily Value on the Nutrition and Supplement Facts Labels
Use for U.S. Nutrition Facts and Supplement Facts Daily Value context when discussing fiber, saturated fat, sodium, calcium, potassium, iodine, magnesium, and vitamins.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 4 connections
Dietary Guidelines for Americans, 2025–2030
Use for current U.S. dietary-guidance context and contrast with zero-plant eating patterns.
- Trust score
- 91
- Publisher
- U.S. Department of Health and Human Services / U.S. Department of Agriculture
- Access
- Official
- Usage
- 3 connections
FDA: Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
Canonicalized from rapid brief compounded-glp1-shadow-market-fda-warning.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 1 connection